Correlation Between Mink Therapeutics and EMCOR

Can any of the company-specific risk be diversified away by investing in both Mink Therapeutics and EMCOR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mink Therapeutics and EMCOR into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mink Therapeutics and EMCOR Group, you can compare the effects of market volatilities on Mink Therapeutics and EMCOR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mink Therapeutics with a short position of EMCOR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mink Therapeutics and EMCOR.

Diversification Opportunities for Mink Therapeutics and EMCOR

0.03

Correlation Coefficient

Mink Therapeutics  EMCOR

Significant diversification

The 3 months correlation between Mink and EMCOR is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Mink Therapeutics and EMCOR Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EMCOR Group and Mink Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mink Therapeutics are associated (or correlated) with EMCOR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EMCOR Group has no effect on the direction of Mink Therapeutics i.e., Mink Therapeutics and EMCOR go up and down completely randomly.

Pair Corralation between Mink Therapeutics and EMCOR

Given the investment horizon of 90 days Mink Therapeutics is expected to under-perform the EMCOR. In addition to that, Mink Therapeutics is 2.69 times more volatile than EMCOR Group. It trades about -0.04 of its total potential returns per unit of risk. EMCOR Group is currently generating about 0.14 per unit of volatility. If you would invest  18,533  in EMCOR Group on September 30, 2024 and sell it today you would earn a total of  27,405  from holding EMCOR Group or generate 147.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mink Therapeutics  vs.  EMCOR Group

Mink Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mink Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

EMCOR Group

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in EMCOR Group are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, EMCOR may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Mink Therapeutics and EMCOR

The main advantage of trading using opposite Mink Therapeutics and EMCOR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mink Therapeutics position performs unexpectedly, EMCOR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EMCOR will offset losses from the drop in EMCOR's long position.

The idea behind Mink Therapeutics and EMCOR Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.